title: Analysis of the complex formation of heparin with protamine by light scattering and analytical ultracentrifugation: implications for blood coagulation management.
abstract: Heparin, a linear glycosaminoglycan, is used in different forms in anticoagulation treatment. Protamine, a highly positive charged peptide containing about 32 amino acids, acts as an antagonist for heparin to restore normal blood coagulation. The complex formation of protamine with heparin was analyzed by a combination of analytical ultracentrifugation and light scattering. Titration of heparin with protamine in blood plasma preparations results in a drastic increase of turbidity, indicating the formation of nanoscale particles. A similar increase of turbidity was observed in physiological saline solution with or without human serum albumin (HSA). Particle size analysis by analytical ultracentrifugation revealed a particle radius of approximately 30 nm for unfractionated heparin and of approximately 60 nm for low molecular weight heparin upon complexation with excess protamine, in agreement with atomic force microscopy data. In the absence of HSA, larger and more heterogeneous particles were observed. The particles obtained were found to be stable for hours. The particle formation kinetics was analyzed by light scattering at different scattering angles and was found to be complete within several minutes. The time course of particle formation suggests a condensation reaction, with sigmoidal traces for low heparin concentrations and quasi-first-order reaction for high heparin concentrations. Under all conditions, the final scattering intensity reached after several minutes was found to be proportional to the amount of heparin in the blood plasma or buffer solution, provided that excess protamine was available and no multiple scattering occurred. On the basis of a direct relation between particle concentration and the heparin concentration present before protaminization, a light scattering assay was developed which permits the quantitative analysis of the heparin concentration in blood plasma and which could complement or even replace the activated clotting time test, which is currently the most commonly used method for blood coagulation management.
authors.affiliation: Institute of Biophysics, Johann Wolfgang Goethe-University Frankfurt, Max von Laue-Strasse 1, 60438 Frankfurt am Main, Germany.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Maurer
authors.forename: Stephanie
authors.initials: S
authors.lastname: Haselbach
authors.forename: Oliver
authors.initials: O
authors.lastname: Klein
authors.forename: Doan
authors.initials: D
authors.lastname: Baykut
authors.forename: Vitali
authors.initials: V
authors.lastname: Vogel
authors.forename: Werner
authors.initials: W
authors.lastname: Mäntele
mesh_terms: D001774:Blood Chemical Analysis / Q000379:methods*; D001777:Blood Coagulation / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism; D006493:Heparin / Q000097:blood / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D008027:Light; D053758:Nanoparticles / Q000737:chemistry; D011479:Protamines / Q000097:blood / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism*; D012542:Scattering, Radiation; D013997:Time Factors; D014461:Ultracentrifugation / Q000379:methods*
chemical_list: D001798:Blood Proteins; D011479:Protamines; D006493:Heparin